Company Filing History:
Years Active: 1992
Title: The Innovations of Edward C. Goodwin
Introduction
Edward C. Goodwin is an accomplished inventor based in Cleveland Heights, Ohio. He is known for his significant contributions to the field of biotechnology, particularly in the area of genetic engineering. His work has led to advancements that enhance the expression of peptides in eukaryotic cells.
Latest Patents
Goodwin holds a patent for the use of a bovine growth hormone (bGH) gDNA polyadenylation signal in the expression of non-bGH peptides. This invention relates to a recombinant DNA compound that includes a promoter, a gene encoding a polypeptide, a bGH polyadenylation signal, and an optional selectable marker. The functional genetic unit created by this invention is capable of being expressed in living cells, which has important implications for biotechnology and medicine.
Career Highlights
Throughout his career, Goodwin has made notable contributions to the field of genetic engineering. His innovative approaches have paved the way for new methods of gene expression, which are crucial for the development of therapeutic proteins and other biotechnological applications. He has worked with various organizations, including The Upjohn Company, where he has furthered his research and development efforts.
Collaborations
Goodwin has collaborated with several esteemed colleagues, including Leonard Edwin Post and Daniel P. Palermo. These partnerships have allowed for the exchange of ideas and expertise, enhancing the impact of their collective work in the field of biotechnology.
Conclusion
Edward C. Goodwin's contributions to genetic engineering and biotechnology have been significant. His innovative patent on the use of a bGH polyadenylation signal demonstrates his commitment to advancing scientific knowledge and applications. His work continues to influence the field and inspire future innovations.